Please login or register first to view this content.
News
NEWS
LATEST NEWS
Untreated Follicular Lymphoma: Obinutuzumab vs Rituximab Efficacy, Safety in Combination With Chemotherapy
Fixed-Duration Venetoclax-Obinutuzumab for Untreated Chronic Lymphocytic Leukemia
Treatment With Hydroxychloroquine-Azithromycin, Progressive Cancer Found to Increase Risk of Death for Patients With COVID-19
KRd Fails to Improve Outcomes Compared With VRd in Newly Diagnosed MM
C difficile Infection May Increase Graft vs Host Disease Risk
Mantle Cell Lymphoma: Novel Scoring System May Aid in Determining Prognosis
UPCOMING MEETINGS
December 7 – 10, 2019
American Society of Hematology Annual Meeting and Exposition
Orlando, FL
DRUG NEWS FROM MPR
FDA Approves New Treatment Option for Multiple Myeloma
Priority Review Granted to Tazemetostat for Follicular Lymphoma Indication
Esperoct Now Available for Treatment of Hemophilia A
Bomedemstat Receives Fast Track Status for Essential Thrombocythemia
Avatrombopag Designated Orphan Drug for Chemo-Induced Thrombocytopenia
Adakveo Approved for Sickle Cell Disease
FDA Grants Accelerated Approval to Brukinsa for Mantle Cell Lymphoma
Reblozyl Approved for Anemia in Beta Thalassemia
Gene Therapy Gets Orphan Drug Status for Gaucher Disease
Ultomiris Receives Approval for Atypical Hemolytic Uremic Syndrome
Want to read more?
Next post in General Hematology
